tanzania times : Latest News and In-depth Analysis
Contact Us
Search

Travel

tanzania times : Latest News and In-depth Analysis
HomeTravel
Travel

Jan 11, 2025

Trina Storage Retains Top Rank in BloombergNEF's 2024 Global Storage Providers and Integrators Bankability Survey

CHANGZHOU,China,Jan. 10,2025-- Recently,Trina Storage has once again secured a top spot in BloombergNEF\'s (BNEF) Energy Storage System Cost Survey 2024,acknowledged for its cutting-edge products,tec
Travel

Outline Global Develops AI-Enabled Geospatial Mapping Platform with Oracle Database 23ai

Melbourne-basedaerial intelligence firm leverages Oracle AI Vector Search to deliver data-intensive geospatial insights for its Australian clients.

Mar 18, 2025
Travel

Yuewen Global IP Awards Creator Forum: The Rise of China's Global IP Ecosystem

SINGAPORE,March 3,2025-- As a pivotal component of the "2024 Yuewen Global IP Awards",the "Yuewen Global IP Awards Creator Forum" was grandly held at Resorts World Sentosa in Singa

Mar 5, 2025
Travel

HONOR Introduced Four AI Technologies at MWC 2025

BARCELONA,Spain,March 3,2025-- Global technology brand HONOR today announced the HONOR ALPHA PLAN,a new corporate strategy to transform HONOR from a smartphone maker to a global leading AI device eco

Mar 5, 2025

All News

Travel

Mass production of high-quality, self-standing, large-diameter single-crystal (111) diamond substrates within reach

Development of n-Type Diamonds for Practical Use in Diamond Semiconductors also Making Advances TOKYO,March 4,2025-- Orbray has developed production technology for the world\'s largest self-standing

Mar 5, 2025
Travel

Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum

MELBOURNE,Australia and INDIANAPOLIS,Ind.,March 4,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) invites investors to join a webinar showcasing the Company\'s late-stag

Mar 5, 2025
Travel

Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) biosimilars referencing PROLIA® and XGEVA®

STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]

Mar 5, 2025
Travel

TotalEnergies ENEOS celebrates the commissioning of SteelAsia's first solar rooftop project

MANILA,Philippines,March 4,2025-- TotalEnergies ENEOS successfully commissioned a 1.9 megawatt-peak (MWp) solar rooftop photovoltaic (PV) system in collaboration with SteelAsia Manufacturing Corporat

Mar 5, 2025
Travel

S Hotels & Resorts achieved a record-breaking revenue of 10,352 million Baht in 2024 with 4Q'24 profit surging by 1.3-fold and proposing a 0.03 baht/share cash dividend

BANGKOK,March 4,2025-- S Hotels and ResortsPCL(SET: SHR),the global hospitality company announced its 2024 financial results,revealing a record revenue of 10.352 billion baht,reflecting the ongoing ex

Mar 5, 2025
Travel

SANY Group Secures Position on 2024 EU Industrial R&D Investment Scoreboard known as Global Innovation Leaders List

– Three Listed Subsidiaries Earn International Accolades for R&D Excellence SHANGHAI,March 4,2025-- The latest2024 EU Industrial R&D Investment Scoreboard released by the European Commission

Mar 5, 2025
1 ... 44 45 46 47 48 49 50 ... 109